Home Salud Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

0

New England Journal of Medicine, Ahead of Print.

​New England Journal of Medicine, Ahead of Print. <br/>   massmed: New England Journal of Medicine: Table of Contents

Salir de la versión móvil